Loading...

Frederick J Meyers

Title(s)Professor, INTERNAL MEDICINE
SchoolUniversity of California, Davis
Phone916-734-2412
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Frontiers of University Training to Unlock the Research Enterprise (FUTURE)
    NIH DP7OD018426Sep 20, 2013 - Aug 31, 2018
    Role: Principal Investigator
    K30 Mentored Clinical research Training Program
    NIH/NCRR K30RR022264Sep 19, 2005 - Jun 30, 2010
    Role: Principal Investigator
    Simultaneous Care: Linking Palliation to Clinical Trials
    NIH/NCI R25CA095260Jul 25, 2002 - Jun 30, 2009
    Role: Principal Investigator
    TRAUMA REDUCTION IN END OF LIFE DECISION MAKING
    NIH/NIA R03AG017391Aug 1, 1999 - Jul 31, 2001
    Role: Principal Investigator
    WEST COAST CENTER FOR PALLIATIVE MEDICINE EDUCATION
    NIH/NCI R25CA067068Sep 30, 1994 - Aug 31, 1998
    Role: Principal Investigator
    Southwest Oncology Group/University of California, Davis
    NIH/NCI U10CA046441Jan 1, 1988 - Dec 31, 2015
    Role: Co-Principal Investigator
    NORTHERN CALIFORNIA ONCOLOGY GROUP
    NIH/NCI U10CA025838Aug 1, 1983 - Jul 31, 1987
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Schweitzer JB, Rainwater JA, Ton H, Giacinto RE, Sauder CAM, Meyers FJ. Building a comprehensive mentoring academy for schools of health. J Clin Transl Sci. 2019 Oct; 3(5):211-217. PMID: 31660245.
      View in: PubMed
    2. Bateni SB, Gingrich AA, Stewart SL, Meyers FJ, Bold RJ, Canter RJ. Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management. BMC Cancer. 2018 Nov 26; 18(1):1166. PMID: 30477454.
      View in: PubMed
    3. Bateni SB, Canter RJ, Meyers FJ, Galante JM, Bold RJ. Palliative Care Training and Decision-Making for Patients with Advanced Cancer: A Comparison of Surgeons and Medical Physicians. Surgery. 2018 Apr 27. PMID: 29709369.
      View in: PubMed
    4. Bateni SB, Bold RJ, Meyers FJ, Canter DJ, Canter RJ. Comparison of common risk stratification indices to predict outcomes among stage IV cancer patients with bowel obstruction undergoing surgery. J Surg Oncol. 2018 Mar; 117(3):479-487. PMID: 29044598.
      View in: PubMed
    5. Bateni SB, David EA, Bold RJ, Cooke DT, Meyers FJ, Canter RJ. Lung resection is safe and feasible among stage IV cancer patients: An American College of Surgeons National Surgical Quality Improvement Program analysis. Surgery. 2017 05; 161(5):1307-1314. PMID: 28011006.
      View in: PubMed
    6. Bateni SB, Meyers FJ, Bold RJ, Canter RJ. Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical Practice. PLoS One. 2016; 11(10):e0165315. PMID: 27780274.
      View in: PubMed
    7. Meyers TJ, Meyers FJ. Editorial--Accelerating precision oncology in the 21st century. Surg Oncol. 2015 Dec; 24(4):359-60. PMID: 26608412.
      View in: PubMed
    8. Meyers FJ, Mathur A, Fuhrmann CN, O'Brien TC, Wefes I, Labosky PA, Duncan DS, August A, Feig A, Gould KL, Friedlander MJ, Schaffer CB, Van Wart A, Chalkley R. The origin and implementation of the Broadening Experiences in Scientific Training programs: an NIH common fund initiative. FASEB J. 2016 Feb; 30(2):507-14. PMID: 26432783.
      View in: PubMed
    9. Batchelder CA, Martinez ML, Duru N, Meyers FJ, Tarantal AF. Three Dimensional Culture of Human Renal Cell Carcinoma Organoids. PLoS One. 2015; 10(8):e0136758. PMID: 26317980.
      View in: PubMed
    10. Mathur A, Meyers FJ, Chalkley R, O'Brien TC, Fuhrmann CN. Transforming training to reflect the workforce. Sci Transl Med. 2015 Apr 29; 7(285):285ed4. PMID: 25925677.
      View in: PubMed
    11. Bateni SB, Meyers FJ, Bold RJ, Canter RJ. Current perioperative outcomes for patients with disseminated cancer. J Surg Res. 2015 Jul; 197(1):118-25. PMID: 25911950.
      View in: PubMed
    12. Meyers FJ, Henderson MC. Graduate medical education reform: moving the elephant. J Gen Intern Med. 2014 Nov; 29(11):1434-5. PMID: 24981781.
      View in: PubMed
    13. Schmitt B, Wacker C, Ikemoto L, Meyers FJ, Pomeroy C. A transparent oversight policy for human anatomical specimen management: the University of California, Davis experience. Acad Med. 2014 Mar; 89(3):410-4. PMID: 24448034.
      View in: PubMed
    14. Knowlton AA, Rainwater JA, Chiamvimonvat N, Bonham AC, Robbins JA, Henderson S, Meyers FJ. Training the translational research teams of the future: UC Davis-HHMI Integrating Medicine into Basic Science program. Clin Transl Sci. 2013 Oct; 6(5):339-46. PMID: 24127920.
      View in: PubMed
    15. Meyers FJ, Hales RE, Young HM, Nesbitt TS, Pomeroy C. Restructuring academic health centers to advance interdisciplinary collaborations: opportunities for psychiatry departments. Acad Psychiatry. 2013 Mar 01; 37(2):72-5. PMID: 23475231.
      View in: PubMed
    16. Shaikh U, Meyers FJ. Commentary: decentralizing quality improvement. Am J Med Qual. 2013 May-Jun; 28(3):261-2. PMID: 23042916.
      View in: PubMed
    17. Meyers FJ, Begg MD, Fleming M, Merchant C. Strengthening the career development of clinical translational scientist trainees: a consensus statement of the Clinical Translational Science Award (CTSA) Research Education and Career Development Committees. Clin Transl Sci. 2012 Apr; 5(2):132-7. PMID: 22507118.
      View in: PubMed
    18. Srinivasan M, Li ST, Meyers FJ, Pratt DD, Collins JB, Braddock C, Skeff KM, West DC, Henderson M, Hales RE, Hilty DM. "Teaching as a Competency": competencies for medical educators. Acad Med. 2011 Oct; 86(10):1211-20. PMID: 21869655.
      View in: PubMed
    19. Meyers FJ, Pomeroy C. Creating the future biomedical research workforce. Sci Transl Med. 2011 Sep 28; 3(102):102fs5. PMID: 21957169.
      View in: PubMed
    20. Tseng WH, Yang X, Wang H, Martinez SR, Chen SL, Meyers FJ, Bold RJ, Canter RJ. Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention. Ann Surg. 2011 Aug; 254(2):333-8. PMID: 21677562.
      View in: PubMed
    21. Heifetz LJ, Christensen SD, Devere-White RW, Meyers FJ. A model for rural oncology. J Oncol Pract. 2011 May; 7(3):168-71. PMID: 21886498.
      View in: PubMed
    22. Wu JN, Meyers FJ, Evans CP. Palliative care in urology. Surg Clin North Am. 2011 Apr; 91(2):429-44, x. PMID: 21419262.
      View in: PubMed
    23. Meyers FJ, Carducci M, Loscalzo MJ, Linder J, Greasby T, Beckett LA. Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials. J Palliat Med. 2011 Apr; 14(4):465-73. PMID: 21413846.
      View in: PubMed
    24. Meyers FJ. Recombinant innovation and translational science trainees. Sci Transl Med. 2010 Jul 07; 2(39):39ed5. PMID: 20610848.
      View in: PubMed
    25. Young-Spint M, Guner YS, Meyers FJ, Schneider P, Khatri VP. Radical palliative surgery: new limits to pursue. Pediatr Surg Int. 2009 Oct; 25(10):917-21. PMID: 19718542.
      View in: PubMed
    26. Lee JS, Bertakis K, Meyers FJ, Chedin E, Tarantal A, Anderson K, Berglund L. Cardiovascular disease in women--challenges deserving a comprehensive translational approach. J Cardiovasc Transl Res. 2009 Sep; 2(3):251-5. PMID: 19655023.
      View in: PubMed
    27. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J Gastroenterol. 2009; 44(1):26-46. PMID: 19159071.
      View in: PubMed
    28. Medici V, Rossaro L, Wegelin JA, Kamboj A, Nakai J, Fisher K, Meyers FJ. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral. Liver Transpl. 2008 Aug; 14(8):1100-6. PMID: 18668666.
      View in: PubMed
    29. Hardin KA, Meyers F, Louie S. Integrating palliative care in severe chronic obstructive lung disease. COPD. 2008 Aug; 5(4):207-20. PMID: 18671146.
      View in: PubMed
    30. Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford ED. Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733. Cancer. 2008 May 15; 112(10):2181-7. PMID: 18404692.
      View in: PubMed
    31. Meyers FJ, Lin A, Sribney WM, Aguilar-Gaxiola S. Diverse populations can use hospice services appropriately. Am J Med. 2008 Apr; 121(4):e1-2. PMID: 18374668.
      View in: PubMed
    32. Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ, Gershwin ME. The immunobiology of mushrooms. Exp Biol Med (Maywood). 2008 Mar; 233(3):259-76. PMID: 18296732.
      View in: PubMed
    33. Martinez SR, Robbins AS, Meyers FJ, Bold RJ, Khatri VP, Goodnight JE. Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma. Cancer. 2008 Mar 01; 112(5):1162-8. PMID: 18213619.
      View in: PubMed
    34. Deane S, Meyers FJ, Gershwin ME. On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years. J Autoimmun. 2008 May; 30(3):180-96. PMID: 18242059.
      View in: PubMed
    35. Meyers FJ, Weinberger SE, Fitzgibbons JP, Glassroth J, Duffy FD, Clayton CP. Redesigning residency training in internal medicine: the consensus report of the Alliance for Academic Internal Medicine Education Redesign Task Force. Acad Med. 2007 Dec; 82(12):1211-9. PMID: 18046131.
      View in: PubMed
    36. Linder JF, Meyers FJ. Palliative care for prison inmates: "don't let me die in prison". JAMA. 2007 Aug 22; 298(8):894-901. PMID: 17712073.
      View in: PubMed
    37. Kalauokalani D, Franks P, Oliver JW, Meyers FJ, Kravitz RL. Can patient coaching reduce racial/ethnic disparities in cancer pain control? Secondary analysis of a randomized controlled trial. Pain Med. 2007 Jan-Feb; 8(1):17-24. PMID: 17244100.
      View in: PubMed
    38. Fitzgibbons JP, Meyers FJ. Redesigning training for internal medicine. Ann Intern Med. 2006 Dec 05; 145(11):865-6; author reply 866. PMID: 17146075.
      View in: PubMed
    39. Tran QN, Urayama S, Meyers FJ. Endoscopic ultrasound-guided celiac plexus neurolysis for pancreatic cancer pain: a single-institution experience and review of the literature. J Support Oncol. 2006 Oct; 4(9):460-2, 464; discussion 463-4. PMID: 17080734.
      View in: PubMed
    40. Knops KM, Srinivasan M, Meyers FJ. Patient desires: a model for assessment of patient preferences for care of severe or terminal illness. Palliat Support Care. 2005 Dec; 3(4):289-99. PMID: 17039984.
      View in: PubMed
    41. Henderson MC, Meyers FJ, Ibrahim T, Tierney LM. Confronting the brutal facts in health care. Am J Med. 2005 Oct; 118(10):1061-3. PMID: 16194632.
      View in: PubMed
    42. Ok JH, Meyers FJ, Evans CP. Medical and surgical palliative care of patients with urological malignancies. J Urol. 2005 Oct; 174(4 Pt 1):1177-82. PMID: 16145365.
      View in: PubMed
    43. Jerant AF, Azari RS, Nesbitt TS, Edwards-Goodbee A, Meyers FJ. The Palliative Care in Assisted Living (PCAL) pilot study: successes, shortfalls, and methodological implications. Soc Sci Med. 2006 Jan; 62(1):199-207. PMID: 15987662.
      View in: PubMed
    44. Zwerdling T, Hamann K, Meyers F. Extending palliative care is there a role for preventive medicine? J Palliat Med. 2005 Jun; 8(3):486-9. PMID: 15992188.
      View in: PubMed
    45. Arora V, Guardiano S, Donaldson D, Storch I, Hemstreet P. Closing the gap between internal medicine training and practice: Recommendations from recent graduates. Am J Med. 2005 Jun; 118(6):680-5; discussion 685-7. PMID: 15922702.
      View in: PubMed
    46. Enders SR, Paterniti DA, Meyers FJ. An approach to develop effective health care decision making for women in prison. J Palliat Med. 2005 Apr; 8(2):432-9. PMID: 15890054.
      View in: PubMed
    47. Meyers FJ, Linder J, Beckett L, Christensen S, Blais J, Gandara DR. Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care. J Pain Symptom Manage. 2004 Dec; 28(6):548-56. PMID: 15589080.
      View in: PubMed
    48. Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004 Sep-Oct; 10(5):294-300. PMID: 15530258.
      View in: PubMed
    49. Rossaro L, Troppmann C, McVicar JP, Sturges M, Fisher K, Meyers FJ. A strategy for the simultaneous provision of pre-operative palliative care for patients awaiting liver transplantation. Transpl Int. 2004 Sep; 17(8):473-5. PMID: 15322744.
      View in: PubMed
    50. Lara PN, Chee KG, Longmate J, Ruel C, Meyers FJ, Gray CR, Edwards RG, Gumerlock PH, Twardowski P, Doroshow JH, Gandara DR. Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial. Cancer. 2004 May 15; 100(10):2125-31. PMID: 15139054.
      View in: PubMed
    51. Zalupski MM, Rankin C, Ryan JR, Lucas DR, Muler J, Lanier KS, Budd GT, Biermann JS, Meyers FJ, Antman K. Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139. Cancer. 2004 Feb 15; 100(4):818-25. PMID: 14770440.
      View in: PubMed
    52. Lara PN, Meyers FJ, Law LY, Dawson NA, Houston J, Lauder I, Edelman MJ. Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma. Cancer. 2004 Jan 01; 100(1):82-8. PMID: 14692027.
      View in: PubMed
    53. Jerant AF, Azari RS, Nesbitt TS, Meyers FJ. The TLC model of palliative care in the elderly: preliminary application in the assisted living setting. Ann Fam Med. 2004 Jan-Feb; 2(1):54-60. PMID: 15053284.
      View in: PubMed
    54. Crist TB, LaRusso NF, Meyers FJ, Clayton CP, Ibrahim T. Centers, institutes, and the future of clinical departments: Part II. Am J Med. 2003 Dec 15; 115(9):745-7. PMID: 14693335.
      View in: PubMed
    55. Lara PN, Quinn DI, Margolin K, Meyers FJ, Longmate J, Frankel P, Mack PC, Turrell C, Valk P, Rao J, Buckley P, Wun T, Gosselin R, Galvin I, Gumerlock PH, Lenz HJ, Doroshow JH, Gandara DR. SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition. Clin Cancer Res. 2003 Oct 15; 9(13):4772-81. PMID: 14581348.
      View in: PubMed
    56. Ibrahim T, O'Connell JB, LaRusso NF, Meyers FJ, Crist TB. Centers, Institutes, and the future of clinical departments: part I. Am J Med. 2003 Sep; 115(4):337-41. PMID: 14509279.
      View in: PubMed
    57. Wild CA, Wang SE, Gandara DR, Lara PN, Meyers FJ, Tanaka M, Houston J, Lauder J, Lau DH. Population-based maximum tolerated dose of irinotecan and carboplatin. Oncology (Williston Park). 2003 Jul; 17(7 Suppl 7):11-6. PMID: 12886868.
      View in: PubMed
    58. Martel CL, Gumerlock PH, Meyers FJ, Lara PN. Current strategies in the management of hormone refractory prostate cancer. Cancer Treat Rev. 2003 Jun; 29(3):171-87. PMID: 12787712.
      View in: PubMed
    59. Meyers FJ, Linder J. Simultaneous care: disease treatment and palliative care throughout illness. J Clin Oncol. 2003 Apr 01; 21(7):1412-5. PMID: 12663735.
      View in: PubMed
    60. Linder JF, Knauf K, Enders SR, Meyers FJ. Prison hospice and pastoral care services in California. J Palliat Med. 2002 Dec; 5(6):903-8. PMID: 12685537.
      View in: PubMed
    61. Gandour-Edwards R, Lara PN, Folkins AK, LaSalle JM, Beckett L, Li Y, Meyers FJ, DeVere-White R. Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma? Cancer. 2002 Sep 01; 95(5):1009-15. PMID: 12209684.
      View in: PubMed
    62. Linder JF, Enders SR, Craig E, Richardson J, Meyers FJ. Hospice care for the incarcerated in the United States: an introduction. J Palliat Med. 2002 Aug; 5(4):549-52. PMID: 12243679.
      View in: PubMed
    63. Lara PN, Meyers FJ, Gray CR, Edwards RG, Gumerlock PH, Kauderer C, Tichauer G, Twardowski P, Doroshow JH, Gandara DR. HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial. Cancer. 2002 May 15; 94(10):2584-9. PMID: 12173324.
      View in: PubMed
    64. Meyers FJ. Surgery for emphysema. N Engl J Med. 2002 Mar 14; 346(11):860-2. PMID: 11898808.
      View in: PubMed
    65. O'Donnell RT, DeNardo SJ, Miers LA, Lamborn KR, Kukis DL, DeNardo GL, Meyers FJ. Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6. Prostate. 2002 Jan 01; 50(1):27-37. PMID: 11757033.
      View in: PubMed
    66. O'Donnell RT, DeNardo SJ, Yuan A, Shen S, Richman CM, Lara PN, Griffith IJ, Goldstein DS, Kukis DL, Martinez GS, Mirick GR, DeNardo GL, Meyers FJ. Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer. Clin Cancer Res. 2001 Jun; 7(6):1561-8. PMID: 11410491.
      View in: PubMed
    67. Oliver JW, Kravitz RL, Kaplan SH, Meyers FJ. Individualized patient education and coaching to improve pain control among cancer outpatients. J Clin Oncol. 2001 Apr 15; 19(8):2206-12. PMID: 11304773.
      View in: PubMed
    68. Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001 Mar 15; 19(6):1728-33. PMID: 11251003.
      View in: PubMed
    69. Meyers FJ, O' Donnell RT. Correspondence re: G. C. de Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000. Clin Cancer Res. 2000 Oct; 6(10):4167. PMID: 11051273.
      View in: PubMed
    70. O'Donnell RT, DeNardo SJ, DeNardo GL, Miers L, Lamborn KR, Kukis DL, Meyers FJ. Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice. Prostate. 2000 Aug 01; 44(3):187-92. PMID: 10906734.
      View in: PubMed
    71. Edelman MJ, Meyers FJ, Miller TR, Williams SG, Gandour-Edwards R, deVere White RW. Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation. Urology. 2000 Apr; 55(4):521-5. PMID: 10736495.
      View in: PubMed
    72. Small EJ, Meyer M, Marshall ME, Reyno LM, Meyers FJ, Natale RB, Lenehan PF, Chen L, Slichenmyer WJ, Eisenberger M. Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. J Clin Oncol. 2000 Apr; 18(7):1440-50. PMID: 10735891.
      View in: PubMed
    73. Lara PN, Kung HJ, Gumerlock PH, Meyers FJ. Molecular biology of prostate carcinogenesis. Crit Rev Oncol Hematol. 1999 Dec; 32(3):197-208. PMID: 10633849.
      View in: PubMed
    74. Edelman MJ, Gandara DR, Meyers FJ, Ishii R, O'Mahony M, Uhrich M, Lauder I, Houston J, Gietzen DW. Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome. Cancer. 1999 Aug 15; 86(4):684-8. PMID: 10440697.
      View in: PubMed
    75. Albertson TE, Meyers F. Cellular drug interaction in the fight against multidrug resistant cancer. Crit Care Med. 1999 Feb; 27(2):244-5. PMID: 10075036.
      View in: PubMed
    76. Linder JF, Blais J, Enders SR, Melberg SE, Meyers FJ. Palliative education: a didactic and experiential approach to teaching end-of-life care. J Cancer Educ. 1999; 14(3):154-60. PMID: 10512332.
      View in: PubMed
    77. Lara PN, Meyers FJ. Treatment options in androgen-independent prostate cancer. Cancer Invest. 1999; 17(2):137-44. PMID: 10071598.
      View in: PubMed
    78. Meyers FJ, Gumerlock PH, Chi SG, Borchers H, Deitch AD, deVere White RW. Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors. Cancer. 1998 Dec 15; 83(12):2534-9. PMID: 9874460.
      View in: PubMed
    79. O'Donnell RT, DeNardo SJ, Shi XB, Mirick GR, DeNardo GL, Kroger LA, Meyers FJ. L6 monoclonal antibody binds prostate cancer. Prostate. 1998 Oct 01; 37(2):91-7. PMID: 9759703.
      View in: PubMed
    80. Geyer CE, Green SJ, Moinpour CM, O'Sullivan J, Goodwin DK, Canfield VA, Meyers FJ, Osborne CK, Martino S. Expanded phase II trial of paclitaxel in metastatic breast cancer: a Southwest Oncology Group study. Breast Cancer Res Treat. 1998 Sep; 51(2):169-81. PMID: 9879778.
      View in: PubMed
    81. Meyers FJ, DeVere White RW. Prostate carcinoma: clarification through clinical insight and molecular diagnostics. West J Med. 1998 Jun; 168(6):525. PMID: 9655997.
      View in: PubMed
    82. Edelman MJ, Siegel D, Meyers F. Follow-up testing after cancer treatment: is it indicated? West J Med. 1998 Jun; 168(6):528-9. PMID: 9656000.
      View in: PubMed
    83. Mack PC, Chi SG, Meyers FJ, Stewart SL, deVere White RW, Gumerlock PH. Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade. Prostate. 1998 Feb 01; 34(2):145-51. PMID: 9465946.
      View in: PubMed
    84. Edelman MJ, Gandara DR, Perez EA, Lau D, Lauder I, Turrell C, Uhrich M, Meyers F. Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy. Invest New Drugs. 1998; 16(1):69-75. PMID: 9740546.
      View in: PubMed
    85. Meyers FJ, Lew D, Lara PN, Williamson S, Marshall E, Balcerzak SP, Rivkin SE, Samlowski W, Crawford ED. Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124). Invest New Drugs. 1998-1999; 16(4):347-51. PMID: 10426670.
      View in: PubMed
    86. Edelman MJ, Meyers FJ, Grennan T, Lauder J, Doroshow J. Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancer. Invest New Drugs. 1998; 16(2):179-82. PMID: 9848583.
      View in: PubMed
    87. DeNardo GL, Kukis DL, DeNardo SJ, Shen S, Mausner LF, O'Donnell RT, Lamborn KR, Meyers FJ, Srivastava SC, Miers LA. Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2. Cancer. 1997 Dec 15; 80(12 Suppl):2576-82. PMID: 9406712.
      View in: PubMed
    88. Edelman MJ, Meyers FJ, Houston J, Lauder I. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma. Semin Oncol. 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PMID: 9346226.
      View in: PubMed
    89. Fisher B, Anderson S, Wickerham DL, DeCillis A, Dimitrov N, Mamounas E, Wolmark N, Pugh R, Atkins JN, Meyers FJ, Abramson N, Wolter J, Bornstein RS, Levy L, Romond EH, Caggiano V, Grimaldi M, Jochimsen P, Deckers P. Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. J Clin Oncol. 1997 May; 15(5):1858-69. PMID: 9164196.
      View in: PubMed
    90. Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med. 1997 May; 12(5):318-31. PMID: 9159703.
      View in: PubMed
    91. Gordon W, Siegmund K, Stanisic TH, McKnight B, Harris IT, Carroll PR, Paradelo JC, Meyers FJ, Chapman RA, Meyskens FL. A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group. Int J Radiat Oncol Biol Phys. 1997 Apr 01; 38(1):83-94. PMID: 9212008.
      View in: PubMed
    92. Sheppard BB, Follette DM, Meyers FJ. Giant carcinoid tumor of the lung. Ann Thorac Surg. 1997 Mar; 63(3):851-2. PMID: 9066421.
      View in: PubMed
    93. de Vere White R, Meyers F, Chi SG, Chamberlain S, Siders D, Lee F, Stewart S, Gumerlock PH. Human androgen receptor expression in prostate cancer following androgen ablation. Eur Urol. 1997; 31(1):1-6. PMID: 9032526.
      View in: PubMed
    94. Borchers H, Meyers FJ, Gumerlock PH, Stewart SL, deVere White RW. NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas. J Urol. 1996 Jun; 155(6):2080-4. PMID: 8618340.
      View in: PubMed
    95. Einstein AB, Wolf M, Halliday KR, Miller GJ, Hafermann M, Lowe BA, Meyers FJ, Leimert JT, Crawford ED. Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study. Urology. 1996 May; 47(5):652-7. PMID: 8650861.
      View in: PubMed
    96. Marshall ME, Wolf MK, Crawford ED, Weiss GR, Ahmann F, Meyers FJ, Blumenstein B, Eisenberger M, Einstein AB. Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group Study. Am J Clin Oncol. 1995 Oct; 18(5):400-2. PMID: 7572756.
      View in: PubMed
    97. Meyers FJ. Screening for cancer. Is it worth it? West J Med. 1995 Aug; 163(2):166-8. PMID: 7571573.
      View in: PubMed
    98. Welborn JL, Kopecky KJ, Meyers FJ, Veith R, Shurafa M, Doroshow JH, Balcerzak SP, Appelbaum FR. Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial. Leukemia. 1995 Jul; 9(7):1126-9. PMID: 7630183.
      View in: PubMed
    99. Leichman CG, Fleming TR, Muggia FM, Tangen CM, Ardalan B, Doroshow JH, Meyers FJ, Holcombe RF, Weiss GR, Mangalik A. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. J Clin Oncol. 1995 Jun; 13(6):1303-11. PMID: 7751875.
      View in: PubMed
    100. Marshall ME, Wolf M, Crawford ED, Thompson IM, Flanigan R, Balcerzak SP, Meyers FJ. Evaluation of low dose alpha-interferon (Roferon-A) in patients with advanced renal cell carcinoma: a Southwest Oncology Group study. Cancer Biother. 1995; 10(3):205-9. PMID: 8547959.
      View in: PubMed
    101. O'Donnell RT, Dea G, Meyers FJ. A phase II trial of concomitant interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in patients with advanced renal cell carcinoma. J Immunother Emphasis Tumor Immunol. 1995 Jan; 17(1):58-61. PMID: 7728306.
      View in: PubMed
    102. Fishman JR, Gumerlock PH, Meyers FJ, deVere White RW. Quantitation of NM23 expression in human prostate tissues. J Urol. 1994 Jul; 152(1):202-7. PMID: 7515452.
      View in: PubMed
    103. Chi SG, deVere White RW, Meyers FJ, Siders DB, Lee F, Gumerlock PH. p53 in prostate cancer: frequent expressed transition mutations. J Natl Cancer Inst. 1994 Jun 15; 86(12):926-33. PMID: 7515114.
      View in: PubMed
    104. Godley PA. Prostate cancer screening. Ann Intern Med. 1994 Jun 15; 120(12):1052; author reply 1053. PMID: 7514368.
      View in: PubMed
    105. Meyers FJ, Chi SG, Fishman JR, deVere White RW, Gumerlock PH. p53 mutations in benign prostatic hyperplasia. J Natl Cancer Inst. 1993 Nov 17; 85(22):1856-8. PMID: 7693956.
      View in: PubMed
    106. Shi XB, Gumerlock PH, Wellman AA, Meares CF, DeNardo GL, Meyers FJ, DeNardo SJ. Rapid PCR construction of a gene containing Lym-1 antibody variable regions. PCR Methods Appl. 1993 Aug; 3(1):46-53. PMID: 8220184.
      View in: PubMed
    107. Livingston RB, Crowley JJ, Thompson T, Williamson SK, Meyers FJ, O'Rourke T, Neefe JR. Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study. Cancer. 1993 Jun 01; 71(11):3509-13. PMID: 8387881.
      View in: PubMed
    108. Marshall ME, Wolf MK, Crawford ED, Taylor S, Blumenstein B, Flanigan R, Meyers FJ, Hynes HE, Barlogie B, Eisenberger M. Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study. Invest New Drugs. 1993 May-Aug; 11(2-3):207-9. PMID: 8262733.
      View in: PubMed
    109. Bukowski RM, Young J, Goodman G, Meyers F, Issell BF, Sergi JS, McLain D, Fyfe G, Finke J. Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinoma. Invest New Drugs. 1993 May-Aug; 11(2-3):211-7. PMID: 8262734.
      View in: PubMed
    110. Daifuku R, Haenftling K, Young J, Groves ES, Turrell C, Meyers FJ. Phase I study of antilipopolysaccharide human monoclonal antibody MAB-T88. Antimicrob Agents Chemother. 1992 Oct; 36(10):2349-51. PMID: 1444318.
      View in: PubMed
    111. Meyers FJ, Blumenstein B, Crawford ED, Hynes HE, Montie JE, Taylor SA, Grossman HB, Natale RB. Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group study. J Urol. 1992 Jul; 148(1):52-4. PMID: 1613880.
      View in: PubMed
    112. Shih Y, Konrad MW, Warren MK, Childs A, Paradise C, Meyers FJ, Groves ES. Suppression and transient induction of lymphokines in cancer patients after administration of polyethylene glycolated interleukin-2. Eur J Immunol. 1992 Mar; 22(3):727-33. PMID: 1547819.
      View in: PubMed
    113. DeVere White RW, Meyers FJ, Soares SE, Miller DG, Soriano TF. Urinary prostate specific antigen levels: role in monitoring the response of prostate cancer to therapy. J Urol. 1992 Mar; 147(3 Pt 2):947-51. PMID: 1371566.
      View in: PubMed
    114. Gumerlock PH, Tang YJ, Meyers FJ, Silva J. Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces. Rev Infect Dis. 1991 Nov-Dec; 13(6):1053-60. PMID: 1775837.
      View in: PubMed
    115. Meyers FJ, Gumerlock PH, Kawasaki ES, Wang AM, deVere White RW, Erlich HA. Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction. Cancer. 1991 Apr 15; 67(8):2087-95. PMID: 2004327.
      View in: PubMed
    116. Gumerlock PH, Poonamallee UR, Meyers FJ, deVere White RW. Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res. 1991 Mar 15; 51(6):1632-7. PMID: 1998954.
      View in: PubMed
    117. Meyers FJ, Paradise C, Scudder SA, Goodman G, Konrad M. A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2. Clin Pharmacol Ther. 1991 Mar; 49(3):307-13. PMID: 2007324.
      View in: PubMed
    118. Welborn JL, Meyers FJ. A three-point approach to anemia. Postgrad Med. 1991 Feb 01; 89(2):179-83, 186. PMID: 1990391.
      View in: PubMed
    119. Perez EA, Scudder SA, Meyers FA, Tanaka MS, Paradise C, Gandara DR. Weekly 24-hour continuous infusion interleukin-2 for metastatic melanoma and renal cell carcinoma: a phase I study. J Immunother (1991). 1991 Feb; 10(1):57-62. PMID: 2012799.
      View in: PubMed
    120. Palmer P, Meyers FJ. An outpatient approach to the delivery of intensive consolidation chemotherapy to adults with acute lymphoblastic leukemia. Oncol Nurs Forum. 1990 Jul-Aug; 17(4):553-8. PMID: 2399168.
      View in: PubMed
    121. Gandara DR, Perez EA, Wold H, Caggiano V, Malec M, Ahn DK, Meyers F, Carlson RW. High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group. Cancer Chemother Pharmacol. 1990; 27(3):243-7. PMID: 2176134.
      View in: PubMed
    122. Meyers FJ, Madewell BR, Gumerlock PH, DeMartini JC. ras p21 expression in ovine pulmonary carcinoma. Vet Immunol Immunopathol. 1989 Dec; 23(3-4):279-91. PMID: 2697961.
      View in: PubMed
    123. Meyers FJ, Gumerlock PH, Teplitz RL, Hatcher SL, deVere White RW. Sequential flow cytometry and single gene analysis by enzymatic amplification and allele specific oligonucleotide hybridization of urothelial cells. J Urol. 1989 Dec; 142(6):1599-601. PMID: 2585644.
      View in: PubMed
    124. Madewell BR, Gumerlock PH, Saunders KA, Meyers FJ, Kraegel SA, Kawasaki ES. Canine and bovine ras family expression detected and discriminated by use of polymerase chain reaction. Anticancer Res. 1989 Nov-Dec; 9(6):1743-9. PMID: 2483304.
      View in: PubMed
    125. Link DP, Lantz BM, Seibert JA, Meyers FJ. Partial splenic embolization guided by blood flow measurements. Invest Radiol. 1989 Sep; 24(9):678-83. PMID: 2807821.
      View in: PubMed
    126. Carlisle DW, Smith KA, Frank E, Meyers FJ. Intraventricular morphine administered by hospice nurses to a patient with intractable pain. Am J Hosp Care. 1989 Jul-Aug; 6(4):36-9. PMID: 2604982.
      View in: PubMed
    127. Gumerlock PH, Meyers FJ, Kokoris SP, Wong G, McCormick FP, de Vere White RW. RAS enzyme-linked immunoblot assay discriminates p21 species: a technique to dissect gene family expression. Anal Biochem. 1989 Jul; 180(1):158-68. PMID: 2683857.
      View in: PubMed
    128. Meyers FJ, Gumerlock PH, Kokoris SP, deVere White RW, McCormick F. Human bladder and colon carcinomas contain activated ras p21. Specific detection of twelfth codon mutants. Cancer. 1989 Jun 01; 63(11):2177-81. PMID: 2655864.
      View in: PubMed
    129. Gandara DR, Wold H, Perez EA, Deisseroth AB, Doroshow J, Meyers F, McWhirter K, Hannigan J, De Gregorio MW. Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen. J Natl Cancer Inst. 1989 May 10; 81(10):790-4. PMID: 2541260.
      View in: PubMed
    130. Meyers FJ, Welborn J, Lewis JP, Flynn N. Infusion carboplatin treatment of relapsed and refractory acute leukemia: evidence of efficacy with minimal extramedullary toxicity at intermediate doses. J Clin Oncol. 1989 Feb; 7(2):173-8. PMID: 2644396.
      View in: PubMed
    131. Gumerlock PH, Meyers FJ, Foster BA, Kawakami TG, deVere White RW. Activated c-N-ras in radiation-induced acute nonlymphocytic leukemia: twelfth codon aspartic acid. Radiat Res. 1989 Feb; 117(2):198-206. PMID: 2646654.
      View in: PubMed
    132. Meyers FJ, Denardo SJ, Macey D, White RD, Unger M. Development of monoclonal antibody imaging of metastatic prostatic carcinoma. Prostate. 1989; 14(3):209-20. PMID: 2471962.
      View in: PubMed
    133. Welborn JL, Lewis JP, Meyers FJ. Impact of reinduction regimens on the clinical course of adult acute nonlymphocytic leukemia. Leukemia. 1988 Nov; 2(11):711-6. PMID: 3054348.
      View in: PubMed
    134. Meyers FJ, Welborn JL, Lewis JP. Improved approach to patients with normocytic anemia. Am Fam Physician. 1988 Aug; 38(2):191-5. PMID: 3407586.
      View in: PubMed
    135. Cardiff RD, Gumerlock PH, Soong MM, Dandekar S, Barry PA, Young LJ, Meyers FJ. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. Oncogene. 1988 Aug; 3(2):205-13. PMID: 2842717.
      View in: PubMed
    136. Gumerlock PH, Edwards BF, Deitch AD, Meyers FJ. Human renal clear cell carcinoma: establishment and characterization of a new cell line (G-2101). In Vitro Cell Dev Biol. 1988 May; 24(5):429-34. PMID: 2453501.
      View in: PubMed
    137. Welborn J, Meyers FJ, O'Grady LF. Renal salt wasting and carboplatinum. Ann Intern Med. 1988 Apr; 108(4):640. PMID: 3279897.
      View in: PubMed
    138. Torti FM, Shortliffe LD, Williams RD, Pitts WC, Kempson RL, Ross JC, Palmer J, Meyers F, Ferrari M, Hannigan J. Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study. J Clin Oncol. 1988 Mar; 6(3):476-83. PMID: 3280742.
      View in: PubMed
    139. Baker WC, Meyers FJ, White RW. Prostatic-specific antigen: clinical experience utilizing immunoperoxidase staining techniques in patients with metastatic prostate cancer. J Surg Oncol. 1988 Mar; 37(3):165-7. PMID: 2451087.
      View in: PubMed
    140. Fernandez B, Lund J, Meyers F. Epithelial membrane antigen expression in benign and malignant squamous epithelium of the head and neck. Otolaryngol Head Neck Surg. 1987 Sep; 97(3):288-93. PMID: 3118310.
      View in: PubMed
    141. Meyers FJ, Meyers FH. Management of chronic pain. Am Fam Physician. 1987 Jul; 36(1):139-46. PMID: 2440292.
      View in: PubMed
    142. Venook AP, Tseng A, Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. J Clin Oncol. 1987 Jun; 5(6):951-5. PMID: 3585449.
      View in: PubMed
    143. Lewis JP, Welborn JL, Meyers FJ, Levy NB, Roschak T. Mast cell disease followed by leukemia with clonal evolution. Leuk Res. 1987; 11(9):769-73. PMID: 3118098.
      View in: PubMed
    144. Chan HY, Meyers FJ, Lewis JP. High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia. Cancer Chemother Pharmacol. 1987; 20(3):265-6. PMID: 3677301.
      View in: PubMed
    145. Meyers FJ, Lewis JP, Marianos S. The integration of cytogenetic analysis into the evaluation of cryptic exudative effusions. Cancer. 1986 Oct 01; 58(7):1479-83. PMID: 3742465.
      View in: PubMed
    146. Meyers FJ, Lewis JP. A focused approach to patients with cancer of unknown primary site. West J Med. 1986 Sep; 145(3):403-4. PMID: 3765625.
      View in: PubMed
    147. Meyers FJ, Goodnight JE. Identification of unsuspected thyroid carcinoma using immunoperoxidase for thyroglobulin. Am J Med. 1986 Jul; 81(1):177-9. PMID: 3524223.
      View in: PubMed
    148. Torti FM, Bristow MM, Lum BL, Carter SK, Howes AE, Aston DA, Brown BW, Hannigan JF, Meyers FJ, Mitchell EP. Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy. Cancer Res. 1986 Jul; 46(7):3722-7. PMID: 3458531.
      View in: PubMed
    149. Meyers FJ, Cardiff RD, Quadro R, Gribble M, Kohler M, Medrano V, Mitchell EP, Shiffman R, William L. Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study. Cancer Treat Rep. 1986 Jun; 70(6):805-6. PMID: 2425963.
      View in: PubMed
    150. Meyers FJ. Tumor biology in explanation of the failure of screening for cancer and in determination of future strategies. Am J Med. 1986 May; 80(5):911-6. PMID: 3706378.
      View in: PubMed
    151. Meyers FJ, Miller CH, Lewis JP. The resolution of phenotypic ambiguity in a case of human leukemia using cytogenetics and immunoglobulin gene rearrangement. Am J Clin Pathol. 1986 Mar; 85(3):372-4. PMID: 3019121.
      View in: PubMed
    152. Bernstein JI, Jacobs C, Meyers F, Rich-Goffinet L, Tanaka L. A phase II study of cisplatin and cytosine arabinoside for recurrent squamous cell carcinoma of the head and neck. Am J Clin Oncol. 1986 Feb; 9(1):58-60. PMID: 3953492.
      View in: PubMed
    153. Meyers FJ, Palmer JM, Freiha FS, Harker EG, Shortliffe LD, Hannigan J, McWhirter K, Torti FM. The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study. J Urol. 1985 Dec; 134(6):1118-21. PMID: 3903223.
      View in: PubMed
    154. Harker WG, Meyers FJ, Freiha FS, Palmer JM, Shortliffe LD, Hannigan JF, McWhirter KM, Torti FM. Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol. 1985 Nov; 3(11):1463-70. PMID: 4056840.
      View in: PubMed
    155. Lewis JP, Meyers FJ, Tanaka L. Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia. Br J Haematol. 1985 Oct; 61(2):261-5. PMID: 4041369.
      View in: PubMed
    156. Lewis JP, Meyers FJ. Chronic myelogenous leukemia and breaks at 9q34. Cancer Genet Cytogenet. 1985 Aug; 17(4):367-8. PMID: 3860284.
      View in: PubMed
    157. Meyers FJ, Lewis B, Mitchell E, William L, Hannigan JF, Gribble M, Torti FM. Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study. Cancer Treat Rep. 1985 Jan; 69(1):143-4. PMID: 3855385.
      View in: PubMed
    158. Torti FM, Porzig KJ, Gandara DR, Volberding P, Mitchell E, Meyers FJ, Kohler M, Gribble M. Phase II trial of 4'-epi-doxorubicin in metastatic melanoma. Cancer Treat Rep. 1984 Dec; 68(12):1509-10. PMID: 6595059.
      View in: PubMed
    159. Meyers FJ, Cardiff RD, Taylor CR, Zuniga M, Radich J. Hairy cell leukemia has a B-cell genotype. Hematol Oncol. 1984 Apr-Jun; 2(2):145-50. PMID: 6430776.
      View in: PubMed
    160. Jacobs C, Meyers F, Hendrickson C, Kohler M, Carter S. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study. Cancer. 1983 Nov 01; 52(9):1563-9. PMID: 6352004.
      View in: PubMed
    161. Meyers FJ. Penile cancer chemotherapy. Recent Results Cancer Res. 1983; 85:143-7. PMID: 6191370.
      View in: PubMed
    162. Meyers FJ, Lewis JP, Marianos S. Case 42-1981: Hodgkin's disease. N Engl J Med. 1982 May 06; 306(18):1115. PMID: 7070416.
      View in: PubMed